NCT04794127 2026-02-18
TRABEPIO
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
Clinical Trials
9 trialsNCT02852486 2025-03-30
EDI-PIO
University of Campinas, Brazil
Phase 2 Completed
NCT00099021 2022-02-11
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed
NCT04867252 2021-09-13
Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome
Khyber Medical University Peshawar
Phase 2 Completed
NCT04883125 2021-05-12
Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
Mansoura University
Phase 2 Completed
NCT01838317 2021-03-01
A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT02347813 2020-06-23
Preventing Squamous Cell Skin Cancer
University of Rochester
Phase 2 Completed
NCT01655719 2017-10-26
Pioglitazone in Thyroid Cancers
University of Michigan
Phase 2 Completed
NCT00427999 2016-11-21
INV342
Novartis
Phase 2 Completed